- Certezze e controversie nella gestione dell’epilessia tumorale - Raccomandazioni AINO - 2007 (Associazione Italiana di Neuro-oncologia) Autori: CM Carapella, B Jandolo, M Maschio, AM Mauro, M Riva, R Rudà, M Scerrati, R Soffietti
- de Boer HM, Mula M, Sander JW. The global burden and stigma of epilepsy. Epilepsy Behav. 2008;12:540-546.
- Dinapoli L, Maschio M, Jandolo B, Fabi A, Pace A, Sperati F, Muti P. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neurol Sci. 2009 May 5. [Epub ahead of print]
- Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 2000;54:1886-1893.
- Hildebrand J, Lecaille C, Perennes J, Delattre JY: Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 2005;65:212-215.
- Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ. Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol. 2003;54:514-520.
- Maschio M, Dinapoli L, Gomellini S, Ferraresi V, Sperati F, Vidiri A, Muti P, Jandolo B. Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neurooncol. 2009 Nov 24. [Epub ahead of print]
- Maschio M, Dinapoli L, Saveriano F, Pompili A, Carapella CM, Vidiri A, Jandolo B. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report. Acta Neurol Scand. 2009;120:210-212.
- Maschio M, Saveriano F, Dinapoli L, Jandolo B. Reversible erectile dysfunction in a patient with brain tumor-related epilepsy in therapy with zonisamide in add-on. J Sex Med. 2009 Jun 29. [Epub ahead of print]
- Maschio M, Dinapoli L, Vidiri A, Pace A, Fabi A, Pompili A, Carapella MC, Jandolo B. The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. J Exp Clin Cancer Res. 2009 May 6;28:60.
- Maschio M, Albani F, Jandolo B, Zarabla A, Contin M, Dinapoli L, Fabi A, Pace A, Baruzzi A. Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. J Neurooncol. 2008;90:217-221.
- Maschio M, Dinapoli L, Zarabla A, Jandolo B. In reference to Bosma et al. The course of neurocognitive functioning in high-grade glioma patients. Neuro Oncol. 2008;10:106-107.
- Maschio M, Dinapoli L, Zarabla A, Pompili A, Carapella CM, Pace A, Giannarelli D, Occhipinti E, Jandolo B. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J Neurooncol. 2008;86:61-70.
- Maschio M, Dinapoli L, Zarabla A, Jandolo B. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct Neurol. 2006;21:15-19.
- Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, Pompili A, Carapella CM, Occhipinti E, Jandolo B. Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol. 2006;80:97-100.
- Maschio M, Jandolo B. Supportive therapy in neuro-oncology. J Exp Clin Cancer Res. 2005;24:17-24.
- Taphoorn MJ, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159-168.
- van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ.Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol. 2009;256:1519-1526.
- van Breemen MS, Wilms EB, Vecht CJ: Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 2007;6:421-430.
- Vecht CJ, van Breemen M: Optimizing therapy of seizures in patients with brain tumors. Neurology 2006, 67(suppl 4):10-13.
|
